M

Medicalgorithmics SA
WSE:MDG

Watchlist Manager
Medicalgorithmics SA
WSE:MDG
Watchlist
Price: 33.85 PLN -0.29% Market Closed
Market Cap: 336.8m PLN

Wall Street
Price Targets

MDG Price Targets Summary
Medicalgorithmics SA

Wall Street analysts forecast MDG stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MDG is 49.57 PLN with a low forecast of 49.09 PLN and a high forecast of 51.03 PLN.

Lowest
Price Target
49.09 PLN
45% Upside
Average
Price Target
49.57 PLN
46% Upside
Highest
Price Target
51.03 PLN
51% Upside
Medicalgorithmics SA Competitors:
Price Targets
BSX
Boston Scientific Corp
40% Upside
099190
I Sens Inc
58% Upside
6823
Rion Co Ltd
39% Upside
EMBLA
Embla Medical hf
1% Upside
ANGO
AngioDynamics Inc
40% Upside
BIM
Biomerieux SA
19% Upside
EUZ
Eckert & Ziegler Strahlen und Medizintechnik AG
50% Upside
ELN
El En SpA
2% Upside

Revenue
Forecast

Revenue Estimate
Medicalgorithmics SA

For the last 12 years the compound annual growth rate for Medicalgorithmics SA's revenue is 7%. The projected CAGR for the next 3 years is 47%.

7%
Past Growth
47%
Estimated Growth
Estimates Accuracy
0%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Medicalgorithmics SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-15%
Average Miss

Net Income
Forecast

Net Income Estimate
Medicalgorithmics SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-70%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MDG's stock price target?
Price Target
49.57 PLN

According to Wall Street analysts, the average 1-year price target for MDG is 49.57 PLN with a low forecast of 49.09 PLN and a high forecast of 51.03 PLN.

What is Medicalgorithmics SA's Revenue forecast?
Projected CAGR
47%

For the last 12 years the compound annual growth rate for Medicalgorithmics SA's revenue is 7%. The projected CAGR for the next 3 years is 47%.

Back to Top